| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| MacLaren R et al. | Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. | 2000 | Crit. Care Med. | pmid:10708180 |
| Karam B et al. | Ergotism precipitated by erythromycin: a rare case of vasospasm. | 2000 | Eur J Vasc Endovasc Surg | pmid:10706847 |
| Brisaert M et al. | Investigation of the chemical stability of an erythromycin-tretinoin lotion by the use of an optimization system. | 2000 | Int J Pharm | pmid:10704802 |
| Bernabéu JA et al. | Microbiological bioassay of erythromycin thiocyanate: optimisation and validation. | 1999 | J Pharm Biomed Anal | pmid:10703990 |
| Suri A et al. | Effects of CYP3A inhibition on the metabolism of cilostazol. | 1999 | Clin Pharmacokinet | pmid:10702888 |
| Hill BC et al. | A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. | 2000 | J. Clin. Microbiol. | pmid:10699011 |
| Vardy SJ and Rose GE | Prevention of cellulitis after open lacrimal surgery: a prospective study of three methods. | 2000 | Ophthalmology | pmid:10690832 |
| Thwaites RT and Frost JA | Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997. | 1999 | J. Clin. Pathol. | pmid:10690169 |
| Noerr B | Erythromycin. | 1999 | Neonatal Netw | pmid:10690102 |
| Yamano K et al. | Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver. | 2000 | J. Pharmacol. Exp. Ther. | pmid:10688631 |
| Fail PA et al. | Comparative effects of quinacrine and erythromycin in adult female rats: a nonsurgical sterilization study. | 2000 | Fertil. Steril. | pmid:10685548 |
| Poyart C et al. | Characterization of the Tn916-like transposon Tn3872 in a strain of abiotrophia defectiva (Streptococcus defectivus) causing sequential episodes of endocarditis in a child. | 2000 | Antimicrob. Agents Chemother. | pmid:10681362 |
| Kohri K et al. | Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages. | 2000 | Eur. Respir. J. | pmid:10678622 |
| Biddle JW and Thornsberry C | In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae. | 1979 | Antimicrob. Agents Chemother. | pmid:106776 |
| Holen S | Antibiotics used traditionally in periodontal therapy. | 1976 | J. Periodontol. | pmid:1067412 |
| Gibson J et al. | Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease. | 2000 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:10673652 |
| Mordi MN et al. | Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. | 2000 | J. Med. Chem. | pmid:10669574 |
| Tang L et al. | Formation of functional heterologous complexes using subunits from the picromycin, erythromycin and oleandomycin polyketide synthases. | 2000 | Chem. Biol. | pmid:10662693 |
| Wilkinson B et al. | Novel octaketide macrolides related to 6-deoxyerythronolide B provide evidence for iterative operation of the erythromycin polyketide synthase. | 2000 | Chem. Biol. | pmid:10662692 |
| From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. | 2000 | JAMA | pmid:10659863 | |
| Nakahara S et al. | Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy. | 1999 | Kurume Med J | pmid:10659597 |
| Allevi P et al. | A new convenient transformation of erythromycin A into clarithromycin. | 1999 | Bioorg. Med. Chem. | pmid:10658579 |
| Mackinnon AM | The problem of intrahepatic cholestasis. | 1975 | Aust N Z J Med | pmid:1065291 |
| Medhus AW et al. | Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. | 2000 | Aliment. Pharmacol. Ther. | pmid:10651665 |
| Heidenreich A et al. | Gastroparesis after retroperitoneal surgery successfully treated with erythromycin. | 2000 | J. Urol. | pmid:10647677 |
| Santos R et al. | Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient. | 2000 | J. Am. Acad. Dermatol. | pmid:10642694 |
| Sharma PK et al. | Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. | 2000 | J. Am. Acad. Dermatol. | pmid:10642679 |
| Honma Y et al. | Effect of erythromycin on Shigella infection of Caco-2 cells. | 2000 | FEMS Immunol. Med. Microbiol. | pmid:10640609 |
| Brueggemann AB et al. | In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. | 2000 | Antimicrob. Agents Chemother. | pmid:10639382 |
| Gisby J and Bryant J | Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. | 2000 | Antimicrob. Agents Chemother. | pmid:10639346 |
| Bajic S et al. | Analysis of erythromycin by liquid chromatography/mass spectrometry using involatile mobile phases with a novel atmospheric pressure ionization source. | 2000 | Rapid Commun. Mass Spectrom. | pmid:10637421 |
| Wu YJ | Highlights of semi-synthetic developments from erythromycin A. | 2000 | Curr. Pharm. Des. | pmid:10637376 |
| MartÃnez-Maldonado M | Postinfectious glomerulonephritis. | 2000 | Am. J. Kidney Dis. | pmid:10636819 |
| Nasrin D et al. | Antibiotic resistance in Streptococcus pneumoniae isolated from children. | 1999 | J Paediatr Child Health | pmid:10634983 |
| Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. | 1999 | MMWR Morb. Mortal. Wkly. Rep. | pmid:10634345 | |
| Weston WL and Morelli JG | Steroid rosacea in prepubertal children. | 2000 | Arch Pediatr Adolesc Med | pmid:10632252 |
| Puri SK and Singh N | Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. | 2000 | Exp. Parasitol. | pmid:10631075 |
| Trinkle R | Comment: evaluation of the clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. | 1999 | Ann Pharmacother | pmid:10630842 |
| Sullivan S et al. | Stevens-Johnson syndrome secondary to erythromycin. | 1999 | Ann Pharmacother | pmid:10630839 |
| GarcÃa Sánchez MJ et al. | [Bacterial resistances]. | 1999 | Aten Primaria | pmid:10630037 |
| Kdesh A et al. | Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. | 1999 | South. Med. J. | pmid:10624910 |
| Desaki M et al. | Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10623585 |
| Novikova SI et al. | Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis. | 2000 | FEMS Microbiol. Lett. | pmid:10620668 |
| Chieppa DM et al. | Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. | 2000 | Eur. J. Clin. Invest. | pmid:10620004 |
| Czeizel AE et al. | A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. | 1999 Nov-Dec | Reprod. Toxicol. | pmid:10613401 |
| Honein MA et al. | Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. | 1999 Dec 18-25 | Lancet | pmid:10609814 |
| Wang JS et al. | Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. | 1999 | Pharmacol. Toxicol. | pmid:10608481 |
| Sato Y et al. | Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine. | 1999 | Cell. Immunol. | pmid:10607432 |
| Ianaro A et al. | Anti-inflammatory activity of macrolide antibiotics. | 2000 | J. Pharmacol. Exp. Ther. | pmid:10604943 |
| Ku YY et al. | Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. | 1999 | J. Antibiot. | pmid:10604761 |
| Esposito S et al. | In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. | 2000 Jan-Feb | Chemotherapy | pmid:10601794 |
| Polk RE et al. | Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. | 1999 | Pharmacotherapy | pmid:10600086 |
| Sugiyama Y et al. | Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. | 1999 | Eur. Respir. J. | pmid:10596699 |
| Portillo A et al. | Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. | 1999 | Int. J. Antimicrob. Agents | pmid:10595574 |
| Doumith M et al. | Interspecies complementation in Saccharopolyspora erythraea : elucidation of the function of oleP1, oleG1 and oleG2 from the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus and generation of new erythromycin derivatives. | 1999 | Mol. Microbiol. | pmid:10594828 |
| Damkier P et al. | Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. | 1999 | Br J Clin Pharmacol | pmid:10594487 |
| Brixius B et al. | [Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. | 1999 Nov-Dec | Klin Padiatr | pmid:10592929 |
| Glass D et al. | A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. | 1999 | Dermatology (Basel) | pmid:10592405 |
| Varaldo PE et al. | Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. | 1999 | Clin. Infect. Dis. | pmid:10589905 |
| Durak H et al. | Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases. | 1999 | Nucl. Med. Biol. | pmid:10587109 |
| McCrea J et al. | Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. | 1999 | J Clin Pharmacol | pmid:10586386 |
| Zarazaga M et al. | In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. | 1999 | Antimicrob. Agents Chemother. | pmid:10582908 |
| Klausner MA | Astemizole use with erythromycin. | 1999 | Ann. Allergy Asthma Immunol. | pmid:10582723 |
| Brown MS et al. | Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643. | 1999 | J. Antibiot. | pmid:10580387 |
| Peng L and Nimni ME | Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. | 1999 | J. Pharm. Pharmacol. | pmid:10579684 |
| Clarke AE et al. | Interaction of bile with erythromycin Lactobionate in vitro. | 1975 | Aust N Z J Med | pmid:1057910 |
| Melo-Cristino J and Fernandes ML | Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. | 1999 | Microb. Drug Resist. | pmid:10566873 |
| Menezes CM et al. | In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence. | 1999 Jul-Aug | Rev. Inst. Med. Trop. Sao Paulo | pmid:10564920 |
| Matsuoka M et al. | Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. | 1999 | FEMS Microbiol. Lett. | pmid:10564793 |
| Morel P et al. | Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. | 1999 | Clin. Exp. Dermatol. | pmid:10564319 |
| Bauer JF et al. | Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. | 1999 | J Pharm Sci | pmid:10564073 |
| Denis A et al. | Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. | 1999 | Bioorg. Med. Chem. Lett. | pmid:10560728 |
| Reeves AR et al. | Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. | 1999 | J. Bacteriol. | pmid:10559177 |
| Malonza IM et al. | A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. | 1999 | J. Infect. Dis. | pmid:10558945 |
| Watanabe M et al. | Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. | 1999 | Xenobiotica | pmid:10553724 |
| Jobe DA et al. | Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. | 1999 | Clin. Diagn. Lab. Immunol. | pmid:10548588 |
| Netherwood T et al. | Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. | 1999 | Appl. Environ. Microbiol. | pmid:10543832 |
| Aoki Y and Kao PN | Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. | 1999 | Antimicrob. Agents Chemother. | pmid:10543746 |
| Maeda K et al. | [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. | 1999 | Nihon Kokyuki Gakkai Zasshi | pmid:10540836 |
| Tobback K et al. | Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. | 1999 | J Chromatogr A | pmid:10536850 |
| Schmidtke LM and Carson J | Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. | 1999 | Vet. Microbiol. | pmid:10535774 |
| Janier M | [Syphilis (except congenital syphilis)]. | 1999 Aug-Sep | Ann Dermatol Venereol | pmid:10530355 |
| Sato A et al. | Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. | 1999 | Pharmacology | pmid:10529657 |
| Yoh M et al. | Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. | 1999 | Can. J. Microbiol. | pmid:10526400 |
| Shortridge VD et al. | Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. | 1999 | Clin. Infect. Dis. | pmid:10524961 |
| Xue Q et al. | A multiplasmid approach to preparing large libraries of polyketides. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10518520 |
| De Winter BY et al. | Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. | 1999 | Gut | pmid:10517907 |
| Ball SE et al. | Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. | 1999 | Clin. Pharmacol. Ther. | pmid:10511065 |
| Kinirons MT et al. | Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. | 1999 | Clin. Pharmacol. Ther. | pmid:10511057 |
| McMullin ST et al. | Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. | 1999 | Arch. Intern. Med. | pmid:10510994 |
| Khan SA et al. | Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. | 1999 | Mol. Cell. Probes | pmid:10508560 |
| Oster P et al. | Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. | 1999 | Antimicrob. Agents Chemother. | pmid:10508033 |
| Miossec-Bartoli C et al. | The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. | 1999 | Antimicrob. Agents Chemother. | pmid:10508024 |
| Rosendal K et al. | Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. | 1976 | Acta Pathol Microbiol Scand B | pmid:1050144 |
| Moreno M et al. | Clinical management of tacrolimus drug interactions in renal transplant patients. | 1999 | Transplant. Proc. | pmid:10500564 |
| Zgoulli S et al. | Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. | 1999 Sep-Oct | J Microencapsul | pmid:10499837 |
| Gibson EM et al. | Transfer of plasmid-mediated antibiotic resistance from streptococci to lactobacilli. | 1979 | J. Bacteriol. | pmid:104973 |
| Cash P et al. | A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. | 1999 | Electrophoresis | pmid:10493130 |
| Moore PA | Dental therapeutic indications for the newer long-acting macrolide antibiotics. | 1999 | J Am Dent Assoc | pmid:10492541 |
| Gómez-Lus R et al. | Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. | 1999 | J. Clin. Microbiol. | pmid:10488213 |
Erythromycin C
Erythromycin C is a lipid of Polyketides (PK) class.
Cross Reference
